Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Appelbaum

Showing results (541-550 of 2,379) with videos related to

Pageof 238
Sort By:
Cerebral Cortex (New York, N.Y. : 1991)|March 27, 2009
Priming and backward influences in the human brain: processing interactions during the stroop interference effectL G Appelbaum, K L Meyerhoff, M G Woldorff
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 17, 2007
Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysisKim L Credito, Lois M Ednie, Peter C Appelbaum
Reproductive Biomedicine Online|July 25, 2008
Anticipating issues related to increasing preimplantation genetic diagnosis use: a research agendaRobert Klitzman, Paul S Appelbaum, Wendy Chung, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Archives of Internal Medicine|November 28, 1994
Sexual relationships between physicians and patientsP S Appelbaum, L M Jorgenson, P K Sutherland
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactamP C Appelbaum, S K Spangler, M R Jacobs
Pageof 238

Showing results (541-550 of 2,379) with videos related to

Sort By:
Pageof 238
Cerebral Cortex (New York, N.Y. : 1991)|March 27, 2009
Priming and backward influences in the human brain: processing interactions during the stroop interference effectL G Appelbaum, K L Meyerhoff, M G Woldorff
Antimicrobial Agents and Chemotherapy|April 1, 1992
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacinS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 17, 2007
Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysisKim L Credito, Lois M Ednie, Peter C Appelbaum
Reproductive Biomedicine Online|July 25, 2008
Anticipating issues related to increasing preimplantation genetic diagnosis use: a research agendaRobert Klitzman, Paul S Appelbaum, Wendy Chung, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1990
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centersP C Appelbaum, S K Spangler, M R Jacobs
The Journal of Antimicrobial Chemotherapy|April 5, 2000
Activity of gemifloxacin, a new broad-spectrum quinolone, against 200 pneumococci by four different susceptibility testing methodsL M Ednie, M R Jacobs, P C Appelbaum
Archives of Internal Medicine|November 28, 1994
Sexual relationships between physicians and patientsP S Appelbaum, L M Jorgenson, P K Sutherland
Antimicrobial Agents and Chemotherapy|September 1, 1994
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodologyG A Pankuch, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|June 1, 1997
Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobesS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Antimicrobial Chemotherapy|August 1, 1993
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactamP C Appelbaum, S K Spangler, M R Jacobs
Pageof 238